News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
Filippo Montemurro: Intriguing preclinical findings of synergy between fulvestrant and capecitabile in ESR1 tumors
Photo of Filippo Montemurro taken from www.irccs.com
Jun 20, 2024, 11:37

Filippo Montemurro: Intriguing preclinical findings of synergy between fulvestrant and capecitabile in ESR1 tumors

Filippo Montemurro, Senior Medical Director at Roche, shared on X:

Pure estrogen receptor antagonists potentiate capecitabine activity in ESR1-mutant breast cancer. Very intriguing preclinical findings of synergy between fulvestrant and capecitabile in ESR1 mutant tumors.

Filippo Montemurro

Read further
Source: Filippo Montemurro/X

Breast Cancer cancer ESR1 estrogen receptor antagonists Filippo Montemurro mutant breast cancer OncoDaily Oncology
Blog
Jun 30, 2024, 05:23
María Mayán: How and why becoming an editor
Blog
Jun 30, 2024, 04:58
Victor Moreno: Botensilimab and balstilimab in treating heavily pre-treated patients with MSS mCRC
Blog
Jun 30, 2024, 04:51
Faisal Mahmood: Meet HEST-1k, a collection of 1,108 ST samples
Positive
Jun 30, 2024, 04:34
Karen Knudsen: Thankful for the incredible partnership with AstraZeneca as we improve lives, together
Blog
Jun 30, 2024, 04:26
Julia Lai-Kwon: Delphi study on alert thresholds and self management advice for immunotherapy at MASCC24
Blog
Jun 30, 2024, 04:14
Mark Lewis: There is so much more to life than what we can see on scans or assay in labs
Insight
Jun 30, 2024, 04:06
Massimiliano Camilli: The use of SGLT2i in cancer patients
Blog
Jun 30, 2024, 04:05
St. Elizabeth Healthcare identified 400th stage I lung cancer patient through pioneering screening program
Blog
Jun 30, 2024, 03:44
Pashtoon Kasi: New staging system that includes ctDNA
Blog
Jun 30, 2024, 03:43
Pashtoon Kasi: Curative potential of immunotherapy for both MSS and MSI-High tumors
Blog
Jun 30, 2024, 03:38
Kimryn Rathmell: National Standards for Cancer Survivorship Care
Blog
Jun 30, 2024, 03:28
Erika Ruiz-Garcia: GI oncology team from National Institute of Cancerology will present 6 posters at ESMOGI24